This page shows you the latest news items in this category. This is page number 10.

Total 56118 results found since Jan 2013.

Cramer ' s week ahead: Pay attention to the Federal Reserve ' s meeting
CNBC's Jim Cramer on Friday gave investors tips for what to focus on during the coming week, highlighting the Federal Reserve's Wednesday decision on interest rate hikes for the rest of the year. "We've got one of the strangest weeks of the year coming because there's an overwhelming sense that…#jimcramer #federalreserve #jaypowell #jeromepowell #disney #orlando #florida #espn #abc #nexstar
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults
The proposed concept encourages effectiveness research that will adapt, optimize and test empirically supported behavioral interventions designed to address common sleep problems in adolescents and young adults with a mental health disorder or who are at risk for developing a mental health disorder.
Source: National Institute of Mental Health - September 16, 2023 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news

Medical office space grabs attention on the First Coast
Changing consumer habits and a growing population has made medical office space a bright spot in the local commercial real estate sector.
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2023 Category: Biotechnology Authors: Nick Blank Source Type: news

NYSE President Lynn Martin: ‘The IPO Market Is Finally (Cautiously) Reopening’
The U.S. IPO market is slowly waking up from an 18-month hibernation, despite the Federal Reserve’s continuing tight monetary policies and economic uncertainties, noticed Lynn Martin, the president of the New York Stock Exchange. “What’s getting my attention is the reopening of the IPO market,…#federalreserves #lynnmartin #newyorkcity #martin #spac #softbank #sftbfowned #klaviyo #stockanalysis
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Scientists already knew that magic mushrooms were good for mental health, but they just discovered the rave drug MDMA can help people struggling with PTSD
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when…#mdma #itsfirst #amyemerson #barbararothbaum #atlanta #naturemedicine #schedule1
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

Ecstasy from your doctor in six months? Makers of MDMA drug for trauma patients to ask FDA to approve psychedelic treatment
MDMA is on the verge of being approved in the US after showing promise as a powerful treatment for post-traumatic stress disorder (PTSD) in its final trial results.
Source: the Mail online | Health - September 15, 2023 Category: Consumer Health News Source Type: news

Success of MDMA in PTSD Study Could Pave the Way for U.S. Approval of the Psychedelic
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy. “It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor. [time-brightcove not-tgx=”true”] ...
Source: TIME: Health - September 15, 2023 Category: Consumer Health News Authors: CARLA K. JOHNSON / AP Tags: Uncategorized wire Source Type: news

TradeTech FX Europe 2023: Buy-side focus their attention on in-flight monitoring as next stage of liquidity provision and transaction costs analytics
Buy-side panellists speaking at the TradeTech FX Europe 2023 conference agreed that significant progress had been made to offer them a clear picture of the FX market in terms of TCA but that more work could be done to develop the in-flight monitoring of analytics. All speakers on a panel exploring…#tca #bhaveshtrivedi #australiansuper #danielchambers #lpa #austrailiansuper #bbh #josephforde #tradetechfxeurope #trade
Source: Reuters: Health - September 15, 2023 Category: Consumer Health News Source Type: news

NHSE intervenes as ICS flags worsening financial deficit
An integrated care system deemed to be a relatively strong performer has changed its full-year financial forecast to a £25m deficit, just four months after agreeing to a breakeven plan.
Source: HSJ - September 15, 2023 Category: UK Health Source Type: news

MDMA-Assisted Therapy Reduced PTSD Symptoms in Diverse Patient Population
(MedPage Today) -- MDMA-assisted psychotherapy proved safe and effective in treating post-traumatic stress disorder (PTSD) symptoms in a diverse patient population, according to findings from the phase III randomized MAPP2 trial. Based on the...
Source: MedPage Today Psychiatry - September 14, 2023 Category: Psychiatry Source Type: news

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval
A study has found that the psychedelic drug MDMA, combined with talk therapy, can reduce symptoms of post-traumatic stress disorder
Source: ABC News: Health - September 14, 2023 Category: Consumer Health News Tags: Health Source Type: news

With the Decongestant SNAFU, the FDA Tries Something New
It’s easy to understand how a medicine like phenylephrine got onto pharmacy shelves in the first place. The common decongestant, used most often as an ingredient in multidrug cold medications like DayQuil and Sudafed PE, was initially designated as “safe and effective” by the Food and Drug Administration (FDA) in 1976, when the agency was newly—and less stringently than today—greenlighting drugs that had been on the market for years before the agency had established any efficacy standards. After a full review of 14 studies (12 unpublished and two published) from pharmaceutical companies—...
Source: TIME: Health - September 14, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news

Firefighters Fear the Toxic Chemicals in Their Gear Could Be Causing Cancer
BOSTON (AP) — Boston firefighter Daniel Ranahan had heard about colleagues getting cancer but he was stunned when doctors discovered a tumor in his chest. He was only 30 and had been in the Boston Fire Department less than a decade. But as he investigated his diagnosis of Hodgkin’s lymphoma in October 2020 and sought successful treatment, he learned he and others wore gear that contained the toxic industrial compound PFAS. [time-brightcove not-tgx=”true”] “You always hear about the dangers. You just never think it’s going be you,” said Ranahan, who stopped working due to the...
Source: TIME: Health - September 14, 2023 Category: Consumer Health News Authors: MICHAEL CASEY / AP Tags: Uncategorized wire Source Type: news

MDMA/Ecstasy Shows Even More Promise in Easing PTSD
THURSDAY, Sept. 14, 2023 -- A new study is adding to evidence that the party drug " ecstasy " can boost the benefits of talk therapy for people suffering from post-traumatic stress disorder (PTSD). In a clinical trial, researchers found that three...
Source: Drugs.com - Daily MedNews - September 14, 2023 Category: General Medicine Source Type: news

MDMA Therapy for PTSD Inches Closer to U.S. Approval
Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.
Source: NYT Health - September 14, 2023 Category: Consumer Health News Authors: Rachel Nuwer Tags: Research Post-Traumatic Stress Disorder Therapy and Rehabilitation Drugs (Pharmaceuticals) Ecstasy (Drug) Psychiatry and Psychiatrists Drug Enforcement Administration Food and Drug Administration MAPS Public Benefit Corporation your-feed Source Type: news